Association Between Decreased Serum Albumin With Risk of Venous Thromboembolism and Mortality in Cancer Patients

The Oncologist
Oliver KönigsbrüggeC Ay

Abstract

In cancer patients, reduced serum albumin has been described as a marker for global declining health and poor prognosis. Our aim was to investigate the association of albumin concentrations with the occurrence of venous thromboembolism (VTE) and mortality in patients with cancer. This investigation was performed in the framework of the Vienna Cancer and Thrombosis Study (CATS), a prospective observational cohort study. We included 1,070 patients with active cancer and assayed serum albumin from venous blood taken at study inclusion. Risk for occurrence of VTE was calculated in a proportional subdistribution hazard regression model with respect to competing risk of death and adjusted for cancer site, leukocyte count, estimated glomerular filtration rate, and cholinesterase. Patients (630 males [58.9%] and 440 females [41.1%]) were observed for a median of 723 days. During follow-up, 90 VTE events (8.4%) and 396 deaths (37.0%) occurred. The median albumin was 41.3 g/L (25th-75th percentile, 37.6-44.2). Patients with albumin levels below the 75th percentile had a 2.2-fold increased risk of VTE (95% confidence interval [CI] 1.09-4.32), as well as a 2.3-fold increased risk of death (95% CI 1.68-3.20) compared with patients with albu...Continue Reading

References

Aug 1, 1996·Controlled Clinical Trials·M Schemper, T L Smith
Apr 16, 2003·British Journal of Haematology·Lars Møller Pedersen, Peter Grundtvig Sørensen
Apr 15, 2010·Thrombosis and Haemostasis·Aaron R FolsomMary Cushman
Sep 30, 2010·Journal of Thrombosis and Haemostasis : JTH·R KanzI Pabinger
Sep 10, 2013·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Veronika SeebacherStephan Polterauer
Jan 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary H LymanUNKNOWN American Society of Clinical Oncology

❮ Previous
Next ❯

Citations

Jun 29, 2016·Gynecologic Oncology·Koji MatsuoLynda D Roman
May 10, 2017·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Madeleine WilleggerJoannis Panotopoulos
Feb 23, 2019·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Kotoe TakayoshiEishi Baba
Apr 10, 2020·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Zahra Matloubi, Zuhair Hassan
Mar 15, 2020·International Journal of Molecular Sciences·Larisa AnghelCristian Stătescu
Jun 6, 2018·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Nora MattilaRiitta Lassila
Jan 18, 2019·Cancers·Silvia RiondinoFiorella Guadagni
Apr 14, 2020·Cancer Management and Research·Chen ZhengXiang Zhao
May 4, 2020·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Yizhen JiangWeijia Fang
Aug 22, 2020·Therapeutic Advances in Medical Oncology·Dinesh K R MedipallyFiona M Lyng
Apr 15, 2020·International Angiology : a Journal of the International Union of Angiology·Yu-Dong LiShu-Xin Zhang
Mar 19, 2021·The Journal of Infectious Diseases·Hui-Yi LinMichael E Hagensee
Jun 20, 2021·Journal of Cardiothoracic and Vascular Anesthesia·Yoshikazu KimuraHidekuni Hidaka
Mar 15, 2021·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Xing XinLing Feng

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.